Literature DB >> 22968731

[Plasticity of WNT signaling activity in colorectal cancer].

D Horst1.   

Abstract

Despite inactivating APC mutations, colorectal cancers express the WNT-effector protein β-catenin in a heterogeneous pattern, with strong nuclear expression confined to a fraction of tumor cells, often only at the tumor's leading edge. WNT-reporter constructs allow separation of these tumor cells with highest WNT/β-Catenin activity, which also express high levels of several putative cancer stem cell antigens. Unexpectedly however, these cells do not show exclusive tumorigenicity in xenograft experiments, thus questioning their general stemness phenotype. Instead, there appears to be significant plasticity between both tumor cells with high and low WNT/β-Catenin activity because both cell types can form tumors which again show mixed populations. Furthermore, WNT/β-Catenin activity in colon cancer cells can be modulated by MAPK signaling thus revealing a means of how other signaling pathways contribute to WNT signaling plasticity in colon cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22968731     DOI: 10.1007/s00292-012-1660-2

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  22 in total

1.  A role for Wnt signalling in self-renewal of haematopoietic stem cells.

Authors:  Tannishtha Reya; Andrew W Duncan; Laurie Ailles; Jos Domen; David C Scherer; Karl Willert; Lindsay Hintz; Roel Nusse; Irving L Weissman
Journal:  Nature       Date:  2003-04-27       Impact factor: 49.962

2.  Patterning and nuclear beta-catenin expression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation.

Authors:  T Kirchner; T Brabletz
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 3.  Wnt/beta-catenin signaling in cancer stemness and malignant behavior.

Authors:  Riccardo Fodde; Thomas Brabletz
Journal:  Curr Opin Cell Biol       Date:  2007-02-16       Impact factor: 8.382

4.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.

Authors:  Catherine A O'Brien; Aaron Pollett; Steven Gallinger; John E Dick
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

5.  Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway.

Authors:  V J Wielenga; R Smits; V Korinek; L Smit; M Kielman; R Fodde; H Clevers; S T Pals
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

6.  Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front.

Authors:  T Brabletz; A Jung; K Hermann; K Günther; W Hohenberger; T Kirchner
Journal:  Pathol Res Pract       Date:  1998       Impact factor: 3.250

7.  A two-step model for colon adenoma initiation and progression caused by APC loss.

Authors:  Reid A Phelps; Stephanie Chidester; Somaye Dehghanizadeh; Jason Phelps; Imelda T Sandoval; Kunal Rai; Talmage Broadbent; Sharmistha Sarkar; Randall W Burt; David A Jones
Journal:  Cell       Date:  2009-05-15       Impact factor: 41.582

8.  Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly.

Authors:  B Rubinfeld; I Albert; E Porfiri; C Fiol; S Munemitsu; P Polakis
Journal:  Science       Date:  1996-05-17       Impact factor: 47.728

9.  Identification of stem cells in small intestine and colon by marker gene Lgr5.

Authors:  Nick Barker; Johan H van Es; Jeroen Kuipers; Pekka Kujala; Maaike van den Born; Miranda Cozijnsen; Andrea Haegebarth; Jeroen Korving; Harry Begthel; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

10.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.